• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂联素水平低预测非酒精性脂肪性肝病的发生:与内脏脂肪指数、内脏脂肪组织厚度和其他肥胖指数无关吗?

Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?

机构信息

Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Department of Medical Laboratory Technology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Arch Physiol Biochem. 2022 Feb;128(1):24-31. doi: 10.1080/13813455.2019.1661496. Epub 2019 Sep 4.

DOI:10.1080/13813455.2019.1661496
PMID:31482741
Abstract

We aimed to study the correlation of adiponectin level with insulin resistance (IR), carotid intima-media thickness (cIMT), and various obesity indices especially visceral adipose tissue (VAT) thickness, and visceral adiposity index (VAI), in patients with NAFLD ( = 41), T2D ( = 22), NAFLD + T2D ( = 41), and healthy subjects ( = 20). Results showed the median level of adiponectin in patients with NAFLD (2.97 μg/mL) and ones with NAFLD + T2D (3.21 μg/mL) is significantly lower rather than in controls (4.39 μg/mL). Moreover, VAI is the only predictor for adiponectin concentration in the combination of patient groups and also in all participants independent of IR and other obesity indices. Adiponectin level had also a positive correlation with cIMT and IR in NAFLD patients. Interestingly, lower level of adiponectin was associated with the presence of T2D, NAFLD, and NAFLD + T2D independent of IR and obesity indices. Collectively, it seems that VAI reflecting visceral adipose tissue function is a possible predictor of adiponectin level.

摘要

我们旨在研究脂联素水平与胰岛素抵抗(IR)、颈动脉内膜中层厚度(cIMT)以及各种肥胖指数(尤其是内脏脂肪组织[VAT]厚度和内脏脂肪指数[VAI])在非酒精性脂肪性肝病(NAFLD)患者( = 41)、2 型糖尿病(T2D)患者( = 22)、NAFLD + T2D 患者( = 41)和健康受试者( = 20)中的相关性。结果显示,NAFLD 患者(2.97μg/mL)和 NAFLD + T2D 患者(3.21μg/mL)的脂联素中位数水平明显低于对照组(4.39μg/mL)。此外,VAI 是患者组和所有参与者中除 IR 和其他肥胖指数外,唯一预测脂联素浓度的因素。脂联素水平与 NAFLD 患者的 cIMT 和 IR 呈正相关。有趣的是,较低的脂联素水平与 T2D、NAFLD 和 NAFLD + T2D 的存在独立于 IR 和肥胖指数相关。总的来说,反映内脏脂肪组织功能的 VAI 似乎是脂联素水平的一个可能预测因素。

相似文献

1
Low level of adiponectin predicts the development of Nonalcoholic fatty liver disease: is it irrespective to visceral adiposity index, visceral adipose tissue thickness and other obesity indices?脂联素水平低预测非酒精性脂肪性肝病的发生:与内脏脂肪指数、内脏脂肪组织厚度和其他肥胖指数无关吗?
Arch Physiol Biochem. 2022 Feb;128(1):24-31. doi: 10.1080/13813455.2019.1661496. Epub 2019 Sep 4.
2
Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.在非酒精性脂肪性肝病的非糖尿病患者中,胰岛素抵抗而非内脏脂肪指数与肝纤维化相关。
Metab Syndr Relat Disord. 2015 Sep;13(7):319-25. doi: 10.1089/met.2015.0018. Epub 2015 May 26.
3
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
4
Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus.内脏脂肪指数作为易患糖尿病个体亚临床动脉粥样硬化的独立标志物。
J Atheroscler Thromb. 2019 Sep 1;26(9):821-834. doi: 10.5551/jat.47274. Epub 2019 Feb 19.
5
Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance.肥胖合并肝脂肪变和胰岛素抵抗男性患者内脏脂肪组织与脂联素、炎症标志物和甲状腺激素的关系。
Arch Med Res. 2013 May;44(4):273-80. doi: 10.1016/j.arcmed.2013.04.001. Epub 2013 Apr 19.
6
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals.即使在体型偏瘦的个体中,脂肪组织功能障碍和内脏脂肪也与肝脏胰岛素抵抗及非酒精性脂肪性肝炎的严重程度相关。
Liver Int. 2022 Nov;42(11):2418-2427. doi: 10.1111/liv.15377. Epub 2022 Aug 18.
7
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial.吡格列酮即使低剂量也能改善 2 型糖尿病患者的非酒精性脂肪性肝病:来自 TOSCA.IT 随机试验亚组的临床和病理生理学见解。
Diabetes Res Clin Pract. 2021 Aug;178:108984. doi: 10.1016/j.diabres.2021.108984. Epub 2021 Jul 24.
8
Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study.年龄、性别和种族在美国成年人中非酒精性脂肪性肝病与内脏脂肪指数相关性中的作用(NHANES 2003-2018):横断面研究。
BMJ Open. 2022 Mar 21;12(3):e058517. doi: 10.1136/bmjopen-2021-058517.
9
Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up.内脏脂肪指数预测非酒精性脂肪性肝病:一项前瞻性研究,随访 4 年。
Liver Int. 2018 Dec;38(12):2294-2300. doi: 10.1111/liv.13941. Epub 2018 Sep 6.
10
Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study.依西那肽改善 2 型糖尿病肥胖患者的心血管危险因素:一项前瞻性研究。
Turk J Med Sci. 2021 Feb 26;51(1):167-174. doi: 10.3906/sag-2004-154.

引用本文的文献

1
Non-alcoholic fatty liver disease (NAFLD) and its association to cardiovascular disease: A comprehensive meta-analysis.非酒精性脂肪性肝病(NAFLD)及其与心血管疾病的关联:一项综合荟萃分析。
JRSM Cardiovasc Dis. 2025 Mar 21;14:20480040251325929. doi: 10.1177/20480040251325929. eCollection 2025 Jan-Dec.
2
Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction.肥胖中的脂联素抵抗:脂联素-瘦素/胰岛素相互作用。
Adv Exp Med Biol. 2024;1460:431-462. doi: 10.1007/978-3-031-63657-8_15.
3
Sex-specific associations between adipokine profiles and carotid-intima media thickness in the Cameron County Hispanic Cohort (CCHC).
卡梅伦县西班牙裔队列(CCHC)中脂肪因子谱与颈动脉内膜中层厚度的性别特异性关联。
Cardiovasc Diabetol. 2023 Aug 31;22(1):231. doi: 10.1186/s12933-023-01968-4.
4
Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD.循环 Ism1 降低 2 型糖尿病风险,但不能降低糖尿病相关的非酒精性脂肪性肝病风险。
Front Endocrinol (Lausanne). 2022 May 30;13:890332. doi: 10.3389/fendo.2022.890332. eCollection 2022.
5
The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis.非酒精性脂肪性肝病和肝纤维化中的内脏脂肪指数——系统评价与荟萃分析
Biomedicines. 2021 Dec 13;9(12):1890. doi: 10.3390/biomedicines9121890.
6
The possible mediatory role of adipokines in the association between low carbohydrate diet and depressive symptoms among overweight and obese women.在超重和肥胖女性中,瘦素等脂肪因子可能在低碳水化合物饮食与抑郁症状之间起中介作用。
PLoS One. 2021 Sep 13;16(9):e0257275. doi: 10.1371/journal.pone.0257275. eCollection 2021.
7
Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease.循环 FAM19A5 水平与非酒精性脂肪性肝病的亚临床动脉粥样硬化呈负相关。
BMC Endocr Disord. 2021 Aug 3;21(1):153. doi: 10.1186/s12902-021-00820-8.
8
Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran.内脏脂肪指数和血浆致动脉粥样硬化指数是心血管疾病风险的有用预测指标:来自伊朗队列研究的证据。
Lipids Health Dis. 2021 Aug 1;20(1):82. doi: 10.1186/s12944-021-01505-w.
9
The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review.内脏脂肪细胞分泌活性分子在腹型肥胖及其相关心血管疾病发生发展中的作用:综述
Biomolecules. 2020 Feb 28;10(3):374. doi: 10.3390/biom10030374.